Avantor Inc (AVTR)
20.78
+0.42
(+2.09%)
USD |
NYSE |
Nov 22, 16:00
20.78
0.00 (0.00%)
After-Hours: 16:18
Avantor Shareholders Equity (Quarterly): 5.553B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.553B |
| June 30, 2024 | 5.435B |
| March 31, 2024 | 5.336B |
| December 31, 2023 | 5.253B |
| September 30, 2023 | 5.099B |
| June 30, 2023 | 5.011B |
| March 31, 2023 | 4.995B |
| December 31, 2022 | 4.855B |
| September 30, 2022 | 4.591B |
| June 30, 2022 | 4.470B |
| March 31, 2022 | 4.358B |
| December 31, 2021 | 4.197B |
| Date | Value |
|---|---|
| September 30, 2021 | 4.105B |
| June 30, 2021 | 2.986B |
| March 31, 2021 | 2.806B |
| December 31, 2020 | 2.674B |
| September 30, 2020 | 2.552B |
| June 30, 2020 | 2.541B |
| March 31, 2020 | 2.440B |
| December 31, 2019 | 2.462B |
| September 30, 2019 | 2.356B |
| June 30, 2019 | 2.411B |
| March 31, 2019 | -3.138B |
| December 31, 2018 | -3.052B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.440B
Minimum
Mar 2020
5.553B
Maximum
Sep 2024
4.086B
Average
4.414B
Median
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.807B |
| Azenta Inc | 1.769B |
| Harvard Bioscience Inc | 65.32M |
| Bionano Genomics Inc | 48.87M |
| Akoya Biosciences Inc | 13.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.84B |
| Total Liabilities (Quarterly) | 7.287B |
| Debt to Equity Ratio | 0.8862 |
| Current Ratio | 1.537 |
| Net Debt Paydown Yield | 1.09% |